AI maps 766 genes linked to schizophrenia, revealing disease as interconnected network

Schizophrenia has long challenged geneticists because its roots are fundamentally different from single-gene disorders. The condition arises from a combination of hundreds of genetic variants, each exerting small effects on different brain processes—some influencing how neurons develop, others altering communication between neurons or the physical organization of brain connections. Understanding this complex architecture required a new approach: AI-based computational models capable of reconstructing how thousands of genes coordinate their activity within the human brain.

A study published in Nature Genetics now provides one of the most detailed genetic pictures of schizophrenia to date. The research team—drawing from the Lieber Institute for Brain Development, the University of Bari, and psychiatric centers across multiple countries—identified 766 genes associated with the disorder. Among these, 641 had not appeared in previous transcriptomic analyses, representing a significant expansion of scientific understanding. Critically, many of these newly identified genes were discovered through long-range genetic regulatory signals, evidence that the genes involved in schizophrenia function as an interconnected network rather than as independent actors.

The study's scope was substantial: researchers analyzed genetic data from more than 102,000 people and examined brain tissue samples from six distinct brain regions obtained from hundreds of donors. This multi-regional approach was essential because the genetic factors contributing to schizophrenia operate across different parts of the brain. The team's findings suggest that rather than acting separately, the genetic variants appear to coordinate and collectively amplify disease risk. The researchers described the discovery using an apt metaphor: they had turned on the lights in an entire neighborhood, whereas previously they could only observe a few lit houses. This expanded view of the genetic landscape now reveals much more of the disease's underlying architecture.

The significance of this work lies in what it enables going forward. With schizophrenia affecting approximately 23 million people worldwide—about one in every 345 people, according to the World Health Organization—understanding its biological mechanisms is a public health imperative. Although specialists have long recognized that genetics play a crucial role, the precise mechanisms by which genetic factors interact have remained unclear. Having a family history increases risk, but does not determine it; some people with affected relatives never develop schizophrenia, while others are diagnosed without known family history. The disease itself manifests through hallucinations, delusions, social isolation, lack of motivation, attention problems, memory difficulties, and thought disorders. This diversity of symptoms likely reflects the complexity of the underlying biological network. Now that scientists have a more complete foundation—a detailed map of the 766 genes and their regulatory relationships—they can more precisely investigate how the disease behaves and develop more targeted approaches to treatment.